BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25028298)

  • 1. Lymphovascular space invasion and tumor differentiation are predictors for postoperative recurrence in patients with pathological stage I nonsmall cell lung cancer.
    Chen YY; Huang TW; Tsai WC; Lin LF; Cheng JB; Lee SC; Chang H
    J Chin Med Assoc; 2014 Aug; 77(8):416-21. PubMed ID: 25028298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of postoperative recurrences in patients with clinical stage I NSCLC.
    Chen YY; Huang TW; Tsai WC; Lin LF; Cheng JB; Chang H; Lee SC
    World J Surg Oncol; 2014 Jan; 12():10. PubMed ID: 24410748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
    Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
    Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
    Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
    Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non-small cell lung cancer.
    Kuo SW; Chen JS; Huang PM; Hsu HH; Lai HS; Lee JM
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1200-1207.e3. PubMed ID: 24993621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
    Qiang G; Xu R; Liu J; Yan J; Xu Y; Di J; Da J; Liang C; Shi B; Guo Y; Liu D
    Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):502-7. PubMed ID: 26359072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
    Moon Y; Lee KY; Park JK
    World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
    Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
    Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of positron emission tomography in resected stage IA non-small cell lung cancer.
    Chou HP; Lin KH; Huang HK; Lin LF; Chen YY; Wu TH; Lee SC; Chang H; Huang TW
    Eur Radiol; 2021 Oct; 31(10):8021-8029. PubMed ID: 33763721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard uptake value of positron emission tomography in clinical stage I lung cancer: clinical application and pathological correlation.
    Huang TW; Hsieh CM; Chang H; Cheng YL; Tzao C; Huang WS; Lee SC
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):869-73. PubMed ID: 22219418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
    Wang S; Xu J; Wang R; Qian F; Yang W; Qiao R; Zhang B; Qian J; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):2006-2015.e2. PubMed ID: 30104070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinicopathologic prediction model for postoperative recurrence in stage Ia non-small cell lung cancer.
    Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1193-9. PubMed ID: 24667022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of lymphovascular invasion for patients with stage I non-small cell lung cancer.
    Hanagiri T; Takenaka M; Oka S; Shigematsu Y; Nagata Y; Shimokawa H; Uramoto H; Yamada S; Tanaka F
    Eur Surg Res; 2011; 47(4):211-7. PubMed ID: 22025080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
    Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
    Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
    Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
    Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.